NCT00004157View on ClinicalTrials.gov

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
Breast CancerGestational Trophoblastic TumorKidney CancerLymphomaNeuroblastomaOvarian CancerSarcomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interleukin-11

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00004157 - Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | Biotech Hunter | Biotech Hunter